Glucoscot MP 2mg/500mg/15mg Tablet SR
Marketer
Ultrascot Biotech Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glucoscot MP 2mg/500mg/15mg Tablet SR
DiabetaComb SR tablets (2mg/500mg/15mg) are a triple-action formulation managing blood glucose. Used alongside diet and exercise, this medication improves glycemic control in adult type 2 diabetics. It enhances insulin efficacy, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and frequency for DiabetaComb SR. Take with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other anti-diabetic medications, alcohol, or missed meals increases hypoglycemia risk; diligent blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Inform your doctor of pre-existing kidney, liver, or heart conditions before commencing treatment. Pregnant or nursing individuals require medical consultation prior to use. Kidney function tests are typically conducted before starting this therapy. Limit alcohol consumption to mitigate potential adverse effects.
Primary Ingredients of Glucoscot MP 2mg/500mg/15mg Tablet SR
No text was provided to rewrite.
Uses of Glucoscot MP 2mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glucoscot MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glucoscot MP 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Take this extended-release tablet with a meal.
Common Side effects of Glucoscot MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glucoscot MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glucoscot MP 2mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Glucoscot MP 2mg/500mg/15mg Tablet SR works:
Glucoscot MP SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone – three distinct antidiabetic agents. This triple therapy offers enhanced blood glucose management when monotherapy or dual combinations prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Glucoscot MP 2mg/500mg/15mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glucoscot MP 2mg/500mg/15mg tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glucoscot MP 2mg/500mg/15mg tablet is likely not safe for use while breastfeeding. Available data from human studies indicates potential transfer to breast milk, posing a risk of harm to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glucoscot MP 2mg/500mg/15mg Tablet SR, potentially requiring dosage modification. Physician consultation is advised. The medication is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glucoscot MP 2mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Glucoscot MP 2mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glucoscot MP 2mg/500mg/15mg Tablet SR :
Should you forget to take a Glucoscot MP 2mg/500mg/15mg Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dosage.
Facts to Know About Glucoscot MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently